194 related articles for article (PubMed ID: 10852966)
1. The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B.
Sylla BS; Murphy K; Cahir-McFarland E; Lane WS; Mosialos G; Kieff E
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7470-5. PubMed ID: 10852966
[TBL] [Abstract][Full Text] [Related]
2. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.
Schuster V; Kreth HW
Immunol Rev; 2000 Dec; 178():21-8. PubMed ID: 11213803
[TBL] [Abstract][Full Text] [Related]
3. A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses.
Sumegi J; Seemayer TA; Huang D; Davis JR; Morra M; Gross TG; Yin L; Romco G; Klein E; Terhorst C; Lanyi A
Leuk Lymphoma; 2002 Jun; 43(6):1189-201. PubMed ID: 12152986
[TBL] [Abstract][Full Text] [Related]
4. A "three-pronged" binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome.
Hwang PM; Li C; Morra M; Lillywhite J; Muhandiram DR; Gertler F; Terhorst C; Kay LE; Pawson T; Forman-Kay JD; Li SC
EMBO J; 2002 Feb; 21(3):314-23. PubMed ID: 11823424
[TBL] [Abstract][Full Text] [Related]
5. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.
Sumegi J; Huang D; Lanyi A; Davis JD; Seemayer TA; Maeda A; Klein G; Seri M; Wakiguchi H; Purtilo DT; Gross TG
Blood; 2000 Nov; 96(9):3118-25. PubMed ID: 11049992
[TBL] [Abstract][Full Text] [Related]
6. Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients.
Morra M; Simarro-Grande M; Martin M; Chen AS; Lanyi A; Silander O; Calpe S; Davis J; Pawson T; Eck MJ; Sumegi J; Engel P; Li SC; Terhorst C
J Biol Chem; 2001 Sep; 276(39):36809-16. PubMed ID: 11477068
[TBL] [Abstract][Full Text] [Related]
7. X-linked lymphoproliferative disease: a progressive immunodeficiency.
Morra M; Howie D; Grande MS; Sayos J; Wang N; Wu C; Engel P; Terhorst C
Annu Rev Immunol; 2001; 19():657-82. PubMed ID: 11244050
[TBL] [Abstract][Full Text] [Related]
8. The abnormal gene in X-linked lymphoproliferative syndrome.
Sullivan JL
Curr Opin Immunol; 1999 Aug; 11(4):431-4. PubMed ID: 10448142
[TBL] [Abstract][Full Text] [Related]
9. SH2D1A mutations in Japanese males with severe Epstein-Barr virus--associated illnesses.
Sumazaki R; Kanegane H; Osaki M; Fukushima T; Tsuchida M; Matsukura H; Shinozaki K; Kimura H; Matsui A; Miyawaki T
Blood; 2001 Aug; 98(4):1268-70. PubMed ID: 11493483
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP).
Brandau O; Schuster V; Weiss M; Hellebrand H; Fink FM; Kreczy A; Friedrich W; Strahm B; Niemeyer C; Belohradsky BH; Meindl A
Hum Mol Genet; 1999 Dec; 8(13):2407-13. PubMed ID: 10556288
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for SH2D1A mutations in X-linked lymphoproliferative disease.
Lappalainen I; Giliani S; Franceschini R; Bonnefoy JY; Duckett C; Notarangelo LD; Vihinen M
Biochem Biophys Res Commun; 2000 Mar; 269(1):124-30. PubMed ID: 10694488
[TBL] [Abstract][Full Text] [Related]
12. Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase.
Aoukaty A; Tan R
J Biol Chem; 2002 Apr; 277(15):13331-7. PubMed ID: 11815622
[TBL] [Abstract][Full Text] [Related]
13. SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients.
Yin L; Ferrand V; Lavoué MF; Hayoz D; Philippe N; Souillet G; Seri M; Giacchino R; Castagnola E; Hodgson S; Sylla BS; Romeo G
Hum Genet; 1999 Nov; 105(5):501-5. PubMed ID: 10598819
[TBL] [Abstract][Full Text] [Related]
14. Analysis of SH2D1A mutations in patients with severe Epstein-Barr virus infections, Burkitt's lymphoma, and Hodgkin's lymphoma.
Parolini O; Kagerbauer B; Simonitsch-Klupp I; Ambros P; Jaeger U; Mann G; Haas OA; Morra M; Gadner H; Terhorst C; Knapp W; Holter W
Ann Hematol; 2002 Aug; 81(8):441-7. PubMed ID: 12224001
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome.
Morra M; Silander O; Calpe S; Choi M; Oettgen H; Myers L; Etzioni A; Buckley R; Terhorst C
Blood; 2001 Sep; 98(5):1321-5. PubMed ID: 11520777
[TBL] [Abstract][Full Text] [Related]
16. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
[TBL] [Abstract][Full Text] [Related]
17. Cellular and molecular pathogenesis of X-linked lymphoproliferative disease.
Moretta A; Bottino C; Parolini S; Moretta L; Biassoni R; Notarangelo LD
Curr Opin Allergy Clin Immunol; 2001 Dec; 1(6):513-7. PubMed ID: 11964734
[TBL] [Abstract][Full Text] [Related]
18. Expression of SH2D1A in five classical Hodgkin's disease-derived cell lines.
Kis LL; Nagy N; Klein G; Klein E
Int J Cancer; 2003 May; 104(5):658-61. PubMed ID: 12594824
[TBL] [Abstract][Full Text] [Related]
19. Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene.
Arico M; Imashuku S; Clementi R; Hibi S; Teramura T; Danesino C; Haber DA; Nichols KE
Blood; 2001 Feb; 97(4):1131-3. PubMed ID: 11159547
[TBL] [Abstract][Full Text] [Related]
20. Differential methylation pattern of the X-linked lymphoproliferative (XLP) disease gene SH2D1A correlates with the cell lineage-specific transcription.
Parolini O; Weinhäusel A; Kagerbauer B; Sassmann J; Holter W; Gadner H; Haas OA; Knapp W
Immunogenetics; 2003 May; 55(2):116-21. PubMed ID: 12709835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]